Chemotherapy Devices Market Size, Share, Growth, Trends, and Forecast 2032

Global Chemotherapy Devices market size accrued earnings worth approximately $11.47 Billion in 2023 and is predicted to gain revenue of about $21.65 Billion by 2032, is set to record a CAGR of nearly 7.31% over the period from 2024 to 2032.

Request Free Sample

Chemotherapy Devices Market Overview

The report covers a forecast and an analysis of the chemotherapy devices market on a global and regional level. The study provides historical data along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints for the chemotherapy devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the chemotherapy devices market on a global and regional level.

This report presents comprehensive analysis and projections for the Chemotherapy Devices Market, covering past, present, and future perspectives. The market estimates featured in the report result from a thorough research methodology, incorporating multiple channels such as primary research, secondary research, and insights from subject-related experts. Calculations for market estimates consider the impact of current market dynamics, as well as economic, social, and political factors influencing the Chemotherapy Devices Market. Additionally, market data is shaped by regulations, government expenditures, and research and development advancements. Positive and negative market changes are both considered in the estimation process.

This report includes a comprehensive view of the Porter’s Five Forces model analysis for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides company market share analysis to give a broader overview of the key players of the chemotherapy devices market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the chemotherapy devices market on a global and regional basis.

Cancer results from the uncontrolled and abnormal proliferation of cells, with over 100 types identified worldwide. It has the potential to metastasize to other body parts, making it a highly lethal global disease. Approximately 33% of cancer cases globally are attributed to tobacco use, while poor diet, obesity, excessive alcohol consumption, and low physical activity contribute to around 10% of cases. Exposure to environmental pollutants and ionizing radiation also plays a role in cancer development, as does inherited genetic factors. Various treatment modalities, including surgery, chemotherapy, radiation therapy, immunotherapy, hormonal therapy, targeted therapy, stem cell therapy, and precision medicine, are employed to combat cancer.

Chemotherapy Devices Market: Report Scope

The rising occurrences of multiple cancer types, such as sarcoma, lung cancer, lymphoma, myeloma, and breast cancer, are likely to act as the major growth driver for the chemotherapy devices market globally. Cancer is the second prominent cause of death globally. According to the Cancer Research UK, cancer was caused almost 9.6 million deaths worldwide in 2018. It further stated that around 17 million new cancer cases were registered in 2018. Furthermore, around 1.7 million new cancer cases are to be detected in the U.S. and more than 6,00,000 people will succumb to the disease in 2018.

Furthermore, growing stress on research and development in oncology and the rising demand for precise and biological drug therapies are likely to propel this market in the future. Efforts taken by various government and non-government organizations to increase cancer awareness and rapid technological advancements are anticipated to create opportunities for the chemotherapy devices market players. However, unwillingness showed by patients to undergo chemotherapy, slight risk of infection due to chemotherapy, and the absence of insurance and reimbursement policies in developing regions might limit this market globally.

Chemotherapy Devices Market: Segmentation

The study provides a decisive view of the chemotherapy devices market by segmenting the market based on product, end-user, and region. The segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032. Based on product, the chemotherapy devices market has been segmented into cannula, pump, catheter, and others. The end-user segment includes home care, clinics, and hospitals.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for chemotherapy devices based on individual segment and types in all the regions and countries.

Some key players of the chemotherapy devices market include

• Baxter International Inc.
• B. Braun Melsungen AG
• Advanced Chemotherapy Technologies
• Becton
• Dickinson and Company
• Halyard Health
• Terumo Corporation
• Fresenius Kabi
• Moog Inc.
• Smiths Group PLC
• Zyno Medical
• and Micrel Medical Devices S.A.

This report segments the global chemotherapy devices market as follows:

By Product

• LVP (Large Volume Pump)
• Syringe Pump
• Elastomeric Pumps

By End-User

• Home Care
• Clinics
• Hospitals

By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa